In the final part of his Pharma Commerce video interview, Dan Walles, VP & GM, traceability and compliance solutions, ...

The agreement includes exemptions for UK-produced drugs and medical devices from Section 232 tariffs, but mandates a ...

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...

In legacy systems, it takes 10-14 days on average to move a prescription from signature to first fill – and half the time, the patient gives up. DTP compresses that window to days or hours by ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to enhance financial flexibility and ...

CMS announced a 44% net savings on 15 high-cost drugs under Medicare, effective January 2027, as part of the Inflation ...

In the second part of his Pharma Commerce video interview, Brad Stewart, BDO’s national life sciences co leader, reveals how ...

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...

As the deadline draws near, the organizations that will succeed under DSCSA are those that understand compliance is not a ...

In final part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, points out how ...

Manufacturers now face a rapidly evolving landscape where tariffs can shift overnight—from metals to paper to other key ...

In today’s demanding clinical development environment—marked by complex protocols, tightened budgets, and heightened scrutiny from regulators, payers, and patients—fragmented trial planning puts ...